We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PSIX:NASDAQPower Solutions International, Inc. Analysis

Data as of 2026-04-26 - not real-time

$77.04

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Power Solutions International (PSIX) trades at $77.04, comfortably above its 20‑day (73.12) and 50‑day (71.44) SMAs, with a bullish MACD histogram (+0.38) and a neutral RSI (54), suggesting short‑term momentum but no clear trend direction.
Fundamentally, the company posted 32.5% revenue growth and a 15.8% profit margin, yet its balance sheet is strained – debt‑to‑equity sits at 86.7%, free cash flow is negative, and the DCF‑derived fair value ($22) is far below the market price, flagging a significant overvaluation (PB 9.94, upside/downside metric ~33%).
Compounding the financial concerns, a series of securities‑fraud class‑action lawsuits disclosed in March‑April 2026 have driven the stock down nearly 30% (from $85.75 to $60.91) and introduce heightened regulatory and legal risk.
With a beta exceeding 3, 30‑day volatility over 95%, and decreasing volume, the stock is highly sensitive to market swings, making it a risky short‑term play despite the underlying growth story.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Pending securities‑fraud litigation and recent 30% price drop
  • Current price far exceeds DCF fair value and PB multiples
  • Extreme volatility and high beta amplify downside risk

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth and profit margins could support recovery
  • High leverage and negative free cash flow remain material concerns
  • Outcome of litigation and potential settlement will drive price direction

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Long‑term growth prospects in specialty industrial machinery
  • Persistent balance‑sheet weakness may limit upside
  • If price adjusts toward fair value, upside potential may re‑emerge

Key Metrics & Analysis

Financial Health

Revenue Growth32.50%
Profit Margin15.78%
P/E Ratio15.6
ROE93.49%
ROA18.21%
Debt/Equity86.73
P/B Ratio9.9
Op. Cash Flow$24.1M
Free Cash Flow$-7148500
Industry P/E31.1

Technical Analysis

TrendNeutral
RSI54.1
Support$54.98
Resistance$88.18
MA 20$73.12
MA 50$71.44
MA 200$77.30
MACDBullish
VolumeDecreasing
Fear & Greed Index88.02

Valuation

Fair Value$22.07
Target Price$102.97
Upside/Downside33.65%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta3.28
Volatility95.32%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.